Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study

Detalhes bibliográficos
Autor(a) principal: Batista,Patricia Parreira
Data de Publicação: 2022
Outros Autores: Perracini,Monica Rodrigues, Amorim,Juleimar Soares Coelho de, Lima,Maria do Carmo Correia de, Lima,Camila Astolphi, Pereira,Daniele Sirineu, Dantas,Renata Gonçalves, Fittipaldi,Etiene Oliveira da Silva, Santos,Aurélio Dias, Campos,Hércules Lázaro Morais, Pereira,Leani Souza Máximo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005031297
Resumo: ABSTRACT BACKGROUND: Social distancing has led to lifestyle changes among older adults during the coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVES: This study aimed to estimate the prevalence risk of sarcopenia (RS) and investigate its associated factors during the COVID-19 pandemic in older Brazilian adults. DESIGN AND SETTING: Cross-sectional observational analysis of baseline data as part of the Remobilize Study. METHODS: Participants in the study were older adults (≥ 60 years), excluding those who were bedridden or institutionalized. The data collected consisted of answers about the RS (SARC-F), functional status, walking, sedentary behavior (SB), pain, comorbidity, and life space mobility. RESULTS: A total of 1,482 older adults (70 ± 8.14 years, 74% women) participated in the study, and an RS prevalence of 17.1% was found. (95% confidence interval [CI] 15.25–19.15%). The adjusted multivariate model showed a significant association between RS and functional limitation (odds ratio [OR]: 19.05; CI 13.00–28.32), comorbidity (OR: 5.11; CI 3.44–7.81), pain (OR: 4.56; CI 3.33–6.28), total walking (OR: 0.99; CI 0.99–1.00), SB of 8–10 hours (OR: 1.85; CI 1.15–2.93), and SB of > 10 hours (OR: 3.93; CI 2.48–6.22). RS was associated with mobility during the pandemic (OR: 0.97; CI 0.96–0.98). P < 0.05. CONCLUSIONS: During the pandemic, the prevalence of RS in older Brazilians was estimated at 17.1%. Moderate to severe functional limitation, comorbidities, presence of pain, walking, longer SB period, and reduced life space mobility significantly contributed to RS in older adults during the pandemic.
id APM-1_b3a44fd5e44dd99a4b04090cb6c0ceb0
oai_identifier_str oai:scielo:S1516-31802022005031297
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize StudySarcopeniaMobility limitationAgedPhysical distancingPandemicsSARC-FRisk of sarcopeniaScreeningOlder adultsABSTRACT BACKGROUND: Social distancing has led to lifestyle changes among older adults during the coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVES: This study aimed to estimate the prevalence risk of sarcopenia (RS) and investigate its associated factors during the COVID-19 pandemic in older Brazilian adults. DESIGN AND SETTING: Cross-sectional observational analysis of baseline data as part of the Remobilize Study. METHODS: Participants in the study were older adults (≥ 60 years), excluding those who were bedridden or institutionalized. The data collected consisted of answers about the RS (SARC-F), functional status, walking, sedentary behavior (SB), pain, comorbidity, and life space mobility. RESULTS: A total of 1,482 older adults (70 ± 8.14 years, 74% women) participated in the study, and an RS prevalence of 17.1% was found. (95% confidence interval [CI] 15.25–19.15%). The adjusted multivariate model showed a significant association between RS and functional limitation (odds ratio [OR]: 19.05; CI 13.00–28.32), comorbidity (OR: 5.11; CI 3.44–7.81), pain (OR: 4.56; CI 3.33–6.28), total walking (OR: 0.99; CI 0.99–1.00), SB of 8–10 hours (OR: 1.85; CI 1.15–2.93), and SB of > 10 hours (OR: 3.93; CI 2.48–6.22). RS was associated with mobility during the pandemic (OR: 0.97; CI 0.96–0.98). P < 0.05. CONCLUSIONS: During the pandemic, the prevalence of RS in older Brazilians was estimated at 17.1%. Moderate to severe functional limitation, comorbidities, presence of pain, walking, longer SB period, and reduced life space mobility significantly contributed to RS in older adults during the pandemic.Associação Paulista de Medicina - APM2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005031297Sao Paulo Medical Journal n.ahead 2022reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/1516-3180.2022.0159.r1.19082022info:eu-repo/semantics/openAccessBatista,Patricia ParreiraPerracini,Monica RodriguesAmorim,Juleimar Soares Coelho deLima,Maria do Carmo Correia deLima,Camila AstolphiPereira,Daniele SirineuDantas,Renata GonçalvesFittipaldi,Etiene Oliveira da SilvaSantos,Aurélio DiasCampos,Hércules Lázaro MoraisPereira,Leani Souza Máximoeng2022-12-15T00:00:00Zoai:scielo:S1516-31802022005031297Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2022-12-15T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study
title Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study
spellingShingle Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study
Batista,Patricia Parreira
Sarcopenia
Mobility limitation
Aged
Physical distancing
Pandemics
SARC-F
Risk of sarcopenia
Screening
Older adults
title_short Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study
title_full Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study
title_fullStr Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study
title_full_unstemmed Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study
title_sort Prevalence risk of sarcopenia in older Brazilian adults during the pandemic: A cross-sectional analysis of the Remobilize Study
author Batista,Patricia Parreira
author_facet Batista,Patricia Parreira
Perracini,Monica Rodrigues
Amorim,Juleimar Soares Coelho de
Lima,Maria do Carmo Correia de
Lima,Camila Astolphi
Pereira,Daniele Sirineu
Dantas,Renata Gonçalves
Fittipaldi,Etiene Oliveira da Silva
Santos,Aurélio Dias
Campos,Hércules Lázaro Morais
Pereira,Leani Souza Máximo
author_role author
author2 Perracini,Monica Rodrigues
Amorim,Juleimar Soares Coelho de
Lima,Maria do Carmo Correia de
Lima,Camila Astolphi
Pereira,Daniele Sirineu
Dantas,Renata Gonçalves
Fittipaldi,Etiene Oliveira da Silva
Santos,Aurélio Dias
Campos,Hércules Lázaro Morais
Pereira,Leani Souza Máximo
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Batista,Patricia Parreira
Perracini,Monica Rodrigues
Amorim,Juleimar Soares Coelho de
Lima,Maria do Carmo Correia de
Lima,Camila Astolphi
Pereira,Daniele Sirineu
Dantas,Renata Gonçalves
Fittipaldi,Etiene Oliveira da Silva
Santos,Aurélio Dias
Campos,Hércules Lázaro Morais
Pereira,Leani Souza Máximo
dc.subject.por.fl_str_mv Sarcopenia
Mobility limitation
Aged
Physical distancing
Pandemics
SARC-F
Risk of sarcopenia
Screening
Older adults
topic Sarcopenia
Mobility limitation
Aged
Physical distancing
Pandemics
SARC-F
Risk of sarcopenia
Screening
Older adults
description ABSTRACT BACKGROUND: Social distancing has led to lifestyle changes among older adults during the coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVES: This study aimed to estimate the prevalence risk of sarcopenia (RS) and investigate its associated factors during the COVID-19 pandemic in older Brazilian adults. DESIGN AND SETTING: Cross-sectional observational analysis of baseline data as part of the Remobilize Study. METHODS: Participants in the study were older adults (≥ 60 years), excluding those who were bedridden or institutionalized. The data collected consisted of answers about the RS (SARC-F), functional status, walking, sedentary behavior (SB), pain, comorbidity, and life space mobility. RESULTS: A total of 1,482 older adults (70 ± 8.14 years, 74% women) participated in the study, and an RS prevalence of 17.1% was found. (95% confidence interval [CI] 15.25–19.15%). The adjusted multivariate model showed a significant association between RS and functional limitation (odds ratio [OR]: 19.05; CI 13.00–28.32), comorbidity (OR: 5.11; CI 3.44–7.81), pain (OR: 4.56; CI 3.33–6.28), total walking (OR: 0.99; CI 0.99–1.00), SB of 8–10 hours (OR: 1.85; CI 1.15–2.93), and SB of > 10 hours (OR: 3.93; CI 2.48–6.22). RS was associated with mobility during the pandemic (OR: 0.97; CI 0.96–0.98). P < 0.05. CONCLUSIONS: During the pandemic, the prevalence of RS in older Brazilians was estimated at 17.1%. Moderate to severe functional limitation, comorbidities, presence of pain, walking, longer SB period, and reduced life space mobility significantly contributed to RS in older adults during the pandemic.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005031297
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005031297
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1516-3180.2022.0159.r1.19082022
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal n.ahead 2022
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209269115256832